There are currently 311 studies, including 229 peer-reviewed studies (as of June 22, 2021) showing that hydroxychloroquine is highly effective for treating both early and late stage COVID patients. It is also effective as a prophylaxis. The drug is very cheap to manufacture. See the data here. More data here. … Continue reading HYDROXYCHLOROQUINE